ProtoKinetix achieves primary objective safety at midpoint of clinical trial

This article was originally published here

All six patients were recruited and treated under this protocol. All primary safety objectives have been achieved at the midpoint in all study participants. As such, the protocol

The post ProtoKinetix achieves primary objective safety at midpoint of clinical trial appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply